WS

Wolfgang Schmidt

Merck: 14 patents #777 of 9,382Top 9%
CL Clariant: 10 patents #155 of 540Top 30%
HA Henkel Kommanditgesellschaft Auf Aktien: 9 patents #152 of 1,846Top 9%
AG Aventis Pharma Deutschland Gmbh: 8 patents #45 of 418Top 15%
Johnson & Johnson: 7 patents #1,413 of 7,810Top 20%
CS Chiesi Farmaceutici S.P.A.: 6 patents #56 of 341Top 20%
CL Clariant Finance (Bvi) Limited: 5 patents #59 of 535Top 15%
A& Aventis Research & Technologies Gmbh &: 5 patents #3 of 131Top 3%
ZI Zimmer: 5 patents #173 of 1,039Top 20%
Hoechst Gmbh: 4 patents #925 of 4,020Top 25%
BG Bundesdruckerei Gmbh: 3 patents #42 of 183Top 25%
GN Galapagos Nv: 3 patents #70 of 177Top 40%
SA Sanofi-Aventis: 2 patents #437 of 1,008Top 45%
DG Desitin Arzneimittel Gmbh: 2 patents #2 of 2Top 100%
GA Glycorex Ab: 2 patents #2 of 19Top 15%
BH Bayer Healthcare: 2 patents #3,312 of 8,007Top 45%
SG Sachleben Chemie Gmbh: 1 patents #26 of 55Top 50%
HG Hoechst Marion Roussel Deutschland Gmbh: 1 patents #7 of 62Top 15%
Hoffmann-La Roche: 1 patents #1,850 of 3,238Top 60%
HL Henkel Limited: 1 patents #428 of 861Top 50%
DA Degussa Ag: 1 patents #925 of 2,007Top 50%
Overall (All Time): #15,155 of 4,157,543Top 1%
98
Patents All Time

Issued Patents All Time

Showing 25 most recent of 98 patents

Patent #TitleCo-InventorsDate
11541132 Radiolabeled compounds Edilio Borroni, Luca Gobbi, Michael Honer, Martin Edelmann, Dale Robert Mitchell +3 more 2023-01-03
10196386 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity Fabio Rancati, Andrea Rizzi, Laura Carzaniga, Ian Linney, Chris Knight 2019-02-05
10004728 Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity Fabio Rancati, Andrea Rizzi, Laura Carzaniga, Ian Linney, Chris Knight 2018-06-26
9662323 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity Laura Carzaniga, Fabio Rancati, Andrea Rizzi, Ian Linney, Michael Barnes +1 more 2017-05-30
9579314 Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity Fabio Rancati, Andrea Rizzi, Laura Carzaniga, Ian Linney, Chris Knight 2017-02-28
9453013 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity Fabio Rancati, Ian Linney, Chris Knight 2016-09-27
9388338 Liquid crystal mixture Ji Li, Toshiaki Nonaka, Ayako Ogawa, Hans-Rolf Dubal, Barbara Hornung +1 more 2016-07-12
9006237 Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases Martin James Inglis Andrews, Mark Stuart Chambers, Giovanni Alessandro Tricarico, Gregory Bar, Kim Louise Hirst +2 more 2015-04-14
8980913 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity Fabio Rancati, Ian Linney, Chris Knight 2015-03-17
8178530 Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases Martin James Inglis Andrews, Paul Edwards, Reginald Christophe Xavier Brys, Philip Huxley, Veronique Birault +6 more 2012-05-15
8173656 Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases Martin James Inglis Andrews, Paul Edwards, Reginald Christophe Xavier Brys, Philip Huxley, Veronique Birault +6 more 2012-05-08
8148369 Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases Martin James Inglis Andrews, Mark Stuart Chambers, Giovanni Alessandro Tricarico, Gregory Bar, Kim Louise Hirst +2 more 2012-04-03
8138193 Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases Martin James Inglis Andrews, Mark Stuart Chambers, Gregory Bar 2012-03-20
8133895 Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases Martin James Inglis Andrews, Mark Stuart Chambers, Gregory Bar 2012-03-13
7982045 2′-substituted 1,1′-biphenyl-2-carboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them Joachim Brendel, Peter Below 2011-07-19
7977352 Triazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases Paul Edwards, Veronique Birault, Friedrich Kroll, Andrew Burritt, Xueliang Tao +2 more 2011-07-12
7915256 Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases Martin James Inglis Andrews, Paul Edwards, Mark Stuart Chambers, Juha Andrew Clase, Gregory Bar +2 more 2011-03-29
7893058 Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases Martin James Inglis Andrews, Paul Edwards, Philip Huxley, Veronique Birault, Mark Stuart Chambers +5 more 2011-02-22
7560147 Liquid-crystal medium Melanie Klasen-Memmer, Matthias Bremer, Detlef Pauluth, Barbara Hornung, Rainer Wingen 2009-07-14
7514582 2′-substituted 1,1′-biphenyl-2-carboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them Joachim Brendel, Peter Below 2009-04-07
7501411 Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases Martin James Inglis Andrews, Paul Edwards, Mark Stuart Chambers, Juha Andrew Clase, Gregory Bar +2 more 2009-03-10
7399505 Fluorinated phenanthrenes and their use in liquid-crystal mixtures Rainer Wingen, Barbara Hornung 2008-07-15
7371437 Liquid-crystalline medium Melanie Klasen-Memmer, Matthias Bremer, Barbara Hornung, Rainer Wingen 2008-05-13
7297378 Fluorinated fused aromatics and their use in liquid-crystal mixtures Rainer Wingen, Barbara Hornung 2007-11-20
7297379 Polyfluorinated fused aromatics and their use in liquid-crystal mixtures Rainer Wingen, Barbara Hornung 2007-11-20